EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest

References

• Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, Villano JL. Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 2014; 23(10):1985-96; PMID:25053711; https://doi.org/10.1158/1055-9965.EPI-14-0275
   PubMed Web of Science ®Google Scholar
• Filatova A, Acker T, Garvalov BK. The cancer stem cell niche(s): The crosstalk between glioma stem cells and their microenvironment. Biochim Biophys Acta 2013; 1830(2):2496-508; PMID:23079585; https://doi.org/10.1016/j.bbagen.2012.10.008
   PubMed Web of Science ®Google Scholar
• Mahon BP, Okoh CO, McKenna R. Targeting aggressive cancers with an artificial sweetener: Could saccharin be a lead compound in anticancer therapy?. Future Oncol 2015; 11(15):2117-9; PMID:26235178; https://doi.org/10.2217/fon.15.137
   PubMed Web of Science ®Google Scholar
• NCCN Clinical Practice Guidelines in Oncoloy. Central Nervous System Cancers.Version 1. 2016.
   Google Scholar
• Agarwala SS, Kirkwood JM. Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma. Oncologist 2000; 5(2):144-51; PMID:10794805; https://doi.org/10.1634/theoncologist.5-2-144
   PubMedGoogle Scholar
• Hirose Y, Berger MS, Pieper RO. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res 2001; 61(5):1957-63; PMID:11280752
   PubMed Web of Science ®Google Scholar
• Zhang J, Stevens MF, Bradshaw TD. Temozolomide: Mechanisms of action, repair and resistance. Curr Mol Pharmacol 2012; 5(1):102-14; PMID:22122467; https://doi.org/10.2174/1874467211205010102
   PubMedGoogle Scholar
• Murray JC, Heng YM, Symonds P, Rice K, Ward W, Huggins M, Todd I, Robins RA. Endothelial monocyte-activating polypeptide-II (EMAP-II): A novel inducer of lymphocyte apoptosis. J Leukoc Biol 2004; 75(5):772-6; PMID:14982944; https://doi.org/10.1189/jlb.1003487
   PubMed Web of Science ®Google Scholar
• Li Z, Liu YH, Xue YX, Liu LB, Xie H. Mechanisms for endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier. J Mol Neurosci 2012; 47(2):408-17; PMID:21969114; https://doi.org/10.1007/s12031-011-9657-5
   PubMed Web of Science ®Google Scholar
• Liu J, Liu L, Xue Y, Meng F, Li S, Wang P, Liu Y. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells. Biochem Pharmacol 2014; 89(4):477-89; PMID:24792437; https://doi.org/10.1016/j.bcp.2014.04.014
   PubMed Web of Science ®Google Scholar
• Qiu ZK, Shen D, Chen YS, Yang QY, Guo CC, Feng BH, Chen ZP. Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells. Chin J Cancer 2014; 33(2):115-22; PMID:23958055; https://doi.org/10.5732/cjc.012.10236
   PubMed Web of Science ®Google Scholar
• Natsumeda M, Aoki H, Miyahara H, Yajima N, Uzuka T, Toyoshima Y, Kakita A, Takahashi H, Fujii Y. Induction of autophagy in temozolomide treated malignant gliomas. Neuropathology 2011; 31(5):486-93; PMID:21269334; https://doi.org/10.1111/j.1440-1789.2010.01197.x
   PubMed Web of Science ®Google Scholar
• Sharma K, Le N, Alotaibi M, Gewirtz DA. Cytotoxic autophagy in cancer therapy. Int J Mol Sci 2014; 15(6):10034-51; PMID:24905404; https://doi.org/10.3390/ijms150610034
   PubMed Web of Science ®Google Scholar
• Fulda S, Kogel D. Cell death by autophagy: Emerging molecular mechanisms and implications for cancer therapy. Oncogene 2015; 34(40):5105-13; PMID:25619832; https://doi.org/10.1038/onc.2014.458
   PubMed Web of Science ®Google Scholar
• Barth S, Glick D, Macleod KF. Autophagy: Assays and artifacts. J Pathol 2010; 221(2):117-24; PMID:20225337; https://doi.org/10.1002/path.2694
   PubMed Web of Science ®Google Scholar
• Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011; 7(3):279-96; PMID:21189453; https://doi.org/10.4161/auto.7.3.14487
   PubMed Web of Science ®Google Scholar
• Puissant A, Fenouille N, Auberger P. When autophagy meets cancer through p62/SQSTM1. Am J Cancer Res 2012; 2(4):397-413; PMID:22860231
   PubMed Web of Science ®Google Scholar
• Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT, Brock C. Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 1997; 23(1):35-61; PMID:9189180; https://doi.org/10.1016/S0305-7372(97)90019-0
   PubMed Web of Science ®Google Scholar
• Perry JA, Kornbluth S. Cdc25 and Wee1: Analogous opposites?. Cell Div 2007; 2:12; PMID:17480229; https://doi.org/10.1186/1747-1028-2-12
   PubMed Web of Science ®Google Scholar
• Lefranc F, Facchini V, Kiss R. Proautophagic drugs: A novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 2007; 12(12):1395-403; PMID:18165616; https://doi.org/10.1634/theoncologist.12-12-1395
   PubMed Web of Science ®Google Scholar
• Roninson IB, Broude EV, Chang BD. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001; 4(5):303-13; PMID:11991684; https://doi.org/10.1054/drup.2001.0213
   PubMed Web of Science ®Google Scholar
• Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296(5573):1655-7; PMID:12040186; https://doi.org/10.1126/science.296.5573.1655
   PubMed Web of Science ®Google Scholar
• Zhuang W, Qin Z, Liang Z. The role of autophagy in sensitizing malignant glioma cells to radiation therapy. Acta Biochim Biophys Sin (Shanghai) 2009; 41(5):341-51; PMID:19430698; https://doi.org/10.1093/abbs/gmp028
   PubMed Web of Science ®Google Scholar
• Kurosu T, Nagao T, Wu N, Oshikawa G, Miura O. Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosis. PLoS One 2013; 8(11):e79478; PMID:24260231; https://doi.org/10.1371/journal.pone.0079478
   PubMed Web of Science ®Google Scholar
• van Horssen R, Eggermont AM, ten Hagen TL. Endothelial monocyte-activating polypeptide-II and its functions in (patho)physiological processes. Cytokine Growth Factor Rev 2006; 17(5):339-48; PMID:16945568; https://doi.org/10.1016/j.cytogfr.2006.08.001
   PubMed Web of Science ®Google Scholar
• Li Z, Liu XB, Liu YH, Xue YX, Wang P, Liu LB, Liu J, Yao YL, Ma J. Roles of Serine/Threonine phosphatases in Low-Dose endothelial Monocyte-Activating Polypeptide-II-Induced opening of Blood-Tumor barrier. J Mol Neurosci 2015; 57(1):11-20; PMID:26087743; https://doi.org/10.1007/s12031-015-0604-8
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen L, Bao Z, Li S, You G, Yan W, Shi Z, Liu Y, Yang P, Zhang W, et al. Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways. Oncol Rep 2011; 26(5):1173-80; PMID:21887474
   PubMed Web of Science ®Google Scholar
• Ananta JS, Paulmurugan R, Massoud TF. Nanoparticle-Delivered antisense MicroRNA-21 Enhances the effects of temozolomide on glioblastoma cells. Mol Pharm 2015; 12(12):4509-17; PMID:26559642; https://doi.org/10.1021/acs.molpharmaceut.5b00694
   PubMed Web of Science ®Google Scholar
• Najbauer J, Kraljik N, Nemeth P. Glioma stem cells: Markers, hallmarks and therapeutic targeting by metformin. Pathol Oncol Res 2014; 20(4):789-97; PMID:25168767; https://doi.org/10.1007/s12253-014-9837-z
   PubMed Web of Science ®Google Scholar
• Binello E, Germano IM. Targeting glioma stem cells: A novel framework for brain tumors. Cancer Sci 2011; 102(11):1958-66; PMID:21848914; https://doi.org/10.1111/j.1349-7006.2011.02064.x
   PubMed Web of Science ®Google Scholar
• Facchino S, Abdouh M, Bernier G. Brain cancer stem cells: current status on glioblastoma multiforme. Cancers (Basel) 2011; 3(2):1777-97; PMID:24212782; https://doi.org/10.3390/cancers3021777
   PubMedGoogle Scholar
• Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer 2006; 6(6):425-36; PMID:16723989; https://doi.org/10.1038/nrc1889
   PubMed Web of Science ®Google Scholar
• Sciuscio D, Diserens AC, van Dommelen K, Martinet D, Jones G, Janzer RC, Pollo C, Hamou MF, Kaina B, Stupp R, et al. Extent and patterns of MGMT promoter methylation in glioblastoma- and respective glioblastoma-derived spheres. Clin Cancer Res 2011; 17(2):255-66; PMID:21097691; https://doi.org/10.1158/1078-0432.CCR-10-1931
   PubMed Web of Science ®Google Scholar
• Beier D, Rohrl S, Pillai DR, Schwarz S, Kunz-Schughart LA, Leukel P, Proescholdt M, Brawanski A, Bogdahn U, Trampe-Kieslich A, et al. Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res 2008; 68(14):5706-15; PMID:18632623; https://doi.org/10.1158/0008-5472.CAN-07-6878
   PubMed Web of Science ®Google Scholar
• Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343(19):1350-4; PMID:11070098; https://doi.org/10.1056/NEJM200011093431901
   PubMed Web of Science ®Google Scholar
• Happold C, Roth P, Silginer M, Florea AM, Lamszus K, Frei K, Deenen R, Reifenberger G, Weller M. Interferon-beta induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells. Mol Cancer Ther 2014; 13(4):948-61; PMID:24526161; https://doi.org/10.1158/1535-7163.MCT-13-0772
   PubMed Web of Science ®Google Scholar
• Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352(10):997-1003; PMID:15758010; https://doi.org/10.1056/NEJMoa043331
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Morselli E, Vicencio JM, Kepp O, Joza N, Tajeddine N, Kroemer G. Life, death and burial: Multifaceted impact of autophagy. Biochem Soc Trans 2008; 36(Pt 5):786-90; PMID:18793137; https://doi.org/10.1042/BST0360786
   PubMed Web of Science ®Google Scholar
• Codogno P, Meijer AJ. Autophagy and signaling: Their role in cell survival and cell death. Cell Death Differ 2005; 12(Suppl 2):1509-18; PMID:16247498; https://doi.org/10.1038/sj.cdd.4401751
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290(5497):1717-21; PMID:11099404; https://doi.org/10.1126/science.290.5497.1717
   PubMed Web of Science ®Google Scholar
• Polager S, Ofir M, Ginsberg D. E2F1 regulates autophagy and the transcription of autophagy genes. Oncogene 2008; 27(35):4860-4; PMID:18408756; https://doi.org/10.1038/onc.2008.117
   PubMed Web of Science ®Google Scholar
• Botrugno OA, Robert T, Vanoli F, Foiani M, Minucci S. Molecular pathways: Old drugs define new pathways: non-histone acetylation at the crossroads of the DNA damage response and autophagy. Clin Cancer Res 2012; 18(9):2436-42; PMID:22512979; https://doi.org/10.1158/1078-0432.CCR-11-0767
   PubMed Web of Science ®Google Scholar
• Zhang J, Hummersone M, Matthews CS, Stevens MF, Bradshaw TD. N3-substituted temozolomide analogs overcome methylguanine-DNA methyltransferase and mismatch repair precipitating apoptotic and autophagic cancer cell death. Oncology 2015; 88(1):28-48; PMID:25277441; https://doi.org/10.1159/000366131
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 2016; 12(1):1-222; PMID:26799652; https://doi.org/10.1080/15548627.2015.1100356
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007; 3(6):542-5; PMID:17611390; https://doi.org/10.4161/auto.4600
   PubMed Web of Science ®Google Scholar
• Germain M, Nguyen AP, Le Grand JN, Arbour N, Vanderluit JL, Park DS, Opferman JT, Slack RS. MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner. EMBO J 2011; 30(2):395-407; PMID:21139567; https://doi.org/10.1038/emboj.2010.327
   PubMed Web of Science ®Google Scholar
• Sakakura K, Takahashi H, Kaira K, Toyoda M, Oyama T, Chikamatsu K. Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma. Cancer Sci 2015; 106(1):1-8; PMID:25338734; https://doi.org/10.1111/cas.12559
   PubMed Web of Science ®Google Scholar
• Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005; 171(4):603-14; PMID:16286508; https://doi.org/10.1083/jcb.200507002
   PubMed Web of Science ®Google Scholar
• Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 2010; 141(7):1146-58; PMID:20541250; https://doi.org/10.1016/j.cell.2010.05.008
   PubMed Web of Science ®Google Scholar
• Cui J, Bai XY, Shi S, Cui S, Hong Q, Cai G, Chen X. Age-related changes in the function of autophagy in rat kidneys. Age (Dordr) 2012; 34(2):329-39; PMID:21455601; https://doi.org/10.1007/s11357-011-9237-1
   PubMed Web of Science ®Google Scholar
• Komatsu M, Wang QJ, Holstein GR, Friedrich VL, Jr., Iwata J, Kominami E, Chait BT, Tanaka K, Yue Z. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc Natl Acad Sci U S A 2007; 104(36):14489-94; PMID:17726112; https://doi.org/10.1073/pnas.0701311104
   PubMed Web of Science ®Google Scholar
• Nezis IP, Simonsen A, Sagona AP, Finley K, Gaumer S, Contamine D, Rusten TE, Stenmark H, Brech A. Ref(2)P, the Drosophila melanogaster homologue of mammalian p62, is required for the formation of protein aggregates in adult brain. J Cell Biol 2008; 180(6):1065-71; PMID:18347073; https://doi.org/10.1083/jcb.200711108
   PubMed Web of Science ®Google Scholar
• Wang QJ, Ding Y, Kohtz DS, Mizushima N, Cristea IM, Rout MP, Chait BT, Zhong Y, Heintz N, Yue Z. Induction of autophagy in axonal dystrophy and degeneration. J Neurosci 2006; 26(31):8057-68; PMID:16885219; https://doi.org/10.1523/JNEUROSCI.2261-06.2006
   PubMed Web of Science ®Google Scholar
• Bartlett BJ, Isakson P, Lewerenz J, Sanchez H, Kotzebue RW, Cumming RC, Harris GL, Nezis IP, Schubert DR, Simonsen A, et al. p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects. Autophagy 2011; 7(6):572-83; PMID:21325881; https://doi.org/10.4161/auto.7.6.14943
   PubMed Web of Science ®Google Scholar
• Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M, Metzger D, Reggiani C, Schiaffino S, Sandri M. Autophagy is required to maintain muscle mass. Cell Metab 2009; 10(6):507-15; PMID:19945408; https://doi.org/10.1016/j.cmet.2009.10.008
   PubMed Web of Science ®Google Scholar
• Meijer AJ, Codogno P. Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol 2004; 36(12):2445-62; PMID:15325584; https://doi.org/10.1016/j.biocel.2004.02.002
   PubMed Web of Science ®Google Scholar
• Choi EJ, Cho BJ, Lee DJ, Hwang YH, Chun SH, Kim HH, Kim IA. Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: Targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases. BMC Cancer 2014; 14:17; PMID:24418474; https://doi.org/10.1186/1471-2407-14-17
   PubMed Web of Science ®Google Scholar
• Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet 2002; 36:617-56; PMID:12429704; https://doi.org/10.1146/annurev.genet.36.060402.113540
   PubMed Web of Science ®Google Scholar
• Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004; 432(7015):316-23; PMID:15549093; https://doi.org/10.1038/nature03097
   PubMed Web of Science ®Google Scholar
• Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73:39-85; PMID:15189136; https://doi.org/10.1146/annurev.biochem.73.011303.073723
   PubMed Web of Science ®Google Scholar
• Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 2004; 11(4):448-57; PMID:14713959; https://doi.org/10.1038/sj.cdd.4401359
   PubMed Web of Science ®Google Scholar
• Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003; 3(5):421-9; PMID:12781359; https://doi.org/10.1016/S1535-6108(03)00110-7
   PubMed Web of Science ®Google Scholar
• Bartek J, Lukas C, Lukas J. Checking on DNA damage in S phase. Nat Rev Mol Cell Biol 2004; 5(10):792-804; PMID:15459660; https://doi.org/10.1038/nrm1493
   PubMed Web of Science ®Google Scholar
• Signore M, Pelacchi F, di Martino S, Runci D, Biffoni M, Giannetti S, Morgante L, De Majo M, Petricoin EF, Stancato L, et al. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo. Cell Death Dis 2014; 5:e1223; PMID:24810059; https://doi.org/10.1038/cddis.2014.188
   PubMed Web of Science ®Google Scholar